Delpor on track with schizophrenia implant late-stage trials
Delpor is sketching out late-stage clinical trial plans for its drug-device combination implant DLP-114 (risperidone) in schizophrenia. After presenting topline…
All articles by Urtė Fultinavičiūtė
Urtė Fultinavičiūtė
@ufulti
Urtė Fultinavičiūtė is a healthcare reporter for Clinical Trials Arena. Urtė's coverage focuses on clinical data management and clinical strategy. Urtė holds an MA in International Journalism from City, University of London.
-
-
FT Summit: AI and regulatory changes at the forefront of industry’s mind
After a few years of disruption caused by the Covid-19 pandemic, it seems that the pharma and biotech industries can…
-
Synchron completes enrolment in neural interface technology trial
US-based endovascular company Synchron has completed patient enrolment in its brain-computer interface (BCI) clinical trial. The company is developing implantable…
-
Can AI remedy the growing pains of digital biomarker development?
Digital biomarkers can potentially open new doors in clinical research. By using digital sensors or other forms of non-traditional digital…